AstraZeneca is a global, science-led biopharmaceutical business and their innovative medicines are used by millions of patients worldwide. AstraZeneca has almost 60,000 employees and an annual revenue of $23 billion (data from 2016 Annual Report). AstraZeneca Gothenburg is one of AstraZeneca’s three global, strategic R&D centres. The site is home to expertise and capabilities across all areas of pharmaceutical development: from discovery science to the finished medicines used in clinical trials and ultimately by patients.
John Wiseman: firstname.lastname@example.org;